These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 21500195)

  • 1. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
    Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
    Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.
    De Re V; De Zorzi M; Caggiari L; Lauletta G; Tornesello ML; Fognani E; Miorin M; Racanelli V; Quartuccio L; Gragnani L; Russi S; Pavone F; Ghersetti M; Costa EG; Casarin P; Bomben R; Mazzaro C; Basaglia G; Berretta M; Vaccher E; Izzo F; Buonaguro FM; De Vita S; Zignego AL; De Paoli P; Dolcetti R
    Oncotarget; 2016 Jun; 7(25):37487-37497. PubMed ID: 27183918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
    Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
    Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
    [No Abstract]   [Full Text] [Related]  

  • 4. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.
    Mosaad YM; Metwally SS; Farag RE; Lotfy ZF; AbdelTwab HE
    Immunol Invest; 2019 Apr; 48(3):321-332. PubMed ID: 30321082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
    Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
    Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma.
    Agúndez JA; García-Martín E; Devesa MJ; Carballo M; Martínez C; Lee-Brunner A; Fernández C; Díaz-Rubio M; Ladero JM
    Oncology; 2012; 82(1):35-40. PubMed ID: 22286521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
    Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
    Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection.
    Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M
    Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants of XRCC1 and risk of hepatocellular carcinoma in chronic hepatitis C patients.
    Arafa M; Besheer T; El-Eraky AM; Abo El-Khair SM; Elsamanoudy AZ
    Br J Biomed Sci; 2019 Apr; 76(2):64-69. PubMed ID: 31025604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
    Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
    Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients.
    Nischalke HD; Berger C; Luda C; Müller T; Berg T; Coenen M; Krämer B; Körner C; Trebicka J; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U
    J Hepatol; 2012 Apr; 56(4):758-64. PubMed ID: 22173151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Correlation of Increased CRP Levels with NFKB1 and TLR2 Polymorphisms in the Case of Morbid Obesity.
    Soydas T; Karaman O; Arkan H; Yenmis G; Ilhan MM; Tombulturk K; Tasan E; Kanigur Sultuybek G
    Scand J Immunol; 2016 Nov; 84(5):278-283. PubMed ID: 27507606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
    Elsayed HM; Nabiel Y; Sheta T
    Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection.
    Divella R; Mazzocca A; Gadaleta C; Simone G; Paradiso A; Quaranta M; Daniele A
    Cancer Genomics Proteomics; 2012; 9(4):193-8. PubMed ID: 22798504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
    Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.